RNAi and CRISPR/Cas9 based in vivo models for drug discovery

被引：0
|
作者：
Premsrirut, Prem K.
Martin, Gregory
Dow, Lukas
Kim, Sang Yong
Zuber, Johannes
Lowe, Scott
Hannon, Greg
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4188
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4188
引用
收藏
页数：2
相关论文
共 50 条
  • [41] RNAI mouse models: revolutionizing drug discovery in vivo
    Premsrirut, Prem
    Fellmann, Christof
    Dow, Lukas
    Zuber, Johannes
    Zender, Lars
    Hannon, Gregory
    Lowe, Scott
    TRANSGENIC RESEARCH, 2014, 23 (05) : 906 - 906
  • [42] RNAi mouse models: Revolutionizing drug discovery in vivo
    Premsrirut, Prem
    Dow, Lukas
    Hannon, Gregory
    Zuber, Johannes
    Lowe, Scott
    Zender, Lars
    Fellmann, Christof
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [43] RNAi mouse models: Revolutionizing drug discovery in vivo
    Premsrirut, Prem K.
    Yoon, BoYoung
    Pesic, Marina
    Dow, Lukas E.
    Zuber, Johannes
    Lowe, Scott W.
    Hannon, Gregory J.
    Zender, Lars
    Fellmann, Christof
    CANCER RESEARCH, 2014, 74 (19)
  • [44] RNAi Mouse Models: Revolutionizing Drug Discovery In Vivo
    Premsrirut, P.
    Dow, L.
    Zuber, J.
    Hannon, G.
    Lowe, S.
    Zender, L.
    Fellmann, C.
    MOLECULAR BIOLOGY OF THE CELL, 2013, 24
  • [45] CRISPR/Cas9 targeted integration prolongs gene expression in vivo
    Stephens, C. J.
    Kashentseva, E.
    Everett, W.
    Kaliberova, L.
    Curiel, D. T.
    HUMAN GENE THERAPY, 2017, 28 (12) : A57 - A58
  • [46] Response to “Unexpected mutations after CRISPR–Cas9 editing in vivo”
    Reynald M Lescarbeau
    Bradley Murray
    Thomas M Barnes
    Nessan Bermingham
    Nature Methods, 2018, 15 (4) : 237 - 237
  • [47] Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
    Zhang, Song
    Shen, Jiangtao
    Li, Dali
    Cheng, Yiyun
    THERANOSTICS, 2021, 11 (02): : 614 - 648
  • [48] A CRISPR/Cas9 Library Screen in Patients' Leukemia Cells In Vivo
    Bahrami, Ehsan
    Becker, Martin
    Wirth, Anna-Katharina
    Schmid, Jan Phillip
    Herold, Tobias
    Oellinger, Rupert
    Rad, Roland
    Jeremias, Irmela
    BLOOD, 2019, 134
  • [49] In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system
    Maddalo, Danilo
    Manchado, Eusebio
    Concepcion, Carla P.
    Bonetti, Ciro
    Vidigal, Joana A.
    Han, Yoon-Chi
    Ogrodowski, Paul
    Crippa, Alessandra
    Rekhtman, Natasha
    de Stanchina, Elisa
    Lowe, Scott W.
    Ventura, Andrea
    NATURE, 2014, 516 (7531) : 423 - +
  • [50] AN IN VIVO TRACEABLE AND MULTIPLEXING CRISPR/CAS9 GENOME EDITING SYSTEM
    Cheng, L.
    Niu, T.
    Liu, Y.
    HAEMATOLOGICA, 2017, 102 : 568 - 568
12345